Durvalumab vs Moroctocog Alfa

## Durvalumab vs Moroctocog Alfa: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Moroctocog Alfa**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Moroctocog Alfa — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Moroctocog Alfa — Protein.